Volunteering for Cancer Research: An Act of Love Penn Medicine News News Motivated by generations past, present, and future, two patients participating in the first-of-its-kind clinical trial are testing an experimental approach to stop cancer in its tracks at the earliest stages of development at the Basser Center. Latest News Doctors Outline New Discoveries in the Fight to Cure Ovarian Cancer Main Line Times News | May 2019 Mainline Media News profiles the work of Dr. Ronny Drapkin, the Basser Center's Director of Gynecologic Cancer Research. How to Quell a Cytokine Storm: International Team Finds New Ways to Dampen an Overactive Immune System Penn Medicine News News | May 2019 Researchers at Penn Medicine and University of Leeds, co-led by the Basser's Roger Greenberg, MD, PhD, have deciphered the structure of a multipart, molecular complex that is also responsible for regulating the immune system and have found new molecular targets for fighting autoimmunity. I Had a Preventive Mastectomy—Then Found Out I Already Had Breast Cancer Yahoo Lifestyle News | May 2019 Alejandra Campoverdi, who has partnered with the Basser Center for our LATINX & BRCA initiative, speaks about her recent preventative mastectomy. Penn Research Provides Insight into Genetic Link to Potential Treatment Response Among BRCA1/2 Breast Cancer Patients Penn Medicine News News | May 2019 New findings from Penn Medicine researchers, including the study’s senior author, Basser’s Katherine L. Nathanson, MD, provide clues about immune response of tumors in patients with BRCA-related breast cancers. The research could shape treatment strategies and clinical trials. Pancreatic cancer treatments show promise in studies, Penn reports Philadelphia Inquirer News | April 2019 The Philadelphia Inquirer highlights a Penn Medicine and Basser Center study, led by Kim Reiss Binder, MD, an assistant professor of Hematology-Oncology, which examines PARP inhibitors in patients with BRCA mutations. Ask the Expert: Senior Genetic Counselor, Dana Clark, Explains BRCA Gene Mutations Health Central News | March 2019 Basser Center genetic counselor Dana Farengo Clark, MS, LCGC, helps to explain BRCA mutations and the process of genetic testing and counseling. Taking the Uncertainty Out of Interpreting BRCA Variants Journal of the American Medical Association News | March 2019 Basser Executive Director Susan Domchek, MD, discusses a new resource with JAMA that may help guide clinical decision-making related to BRCA genetic mutations. Lead Researcher Discusses Durvalumab/Olaparib Combo in Breast Cancer OncLive News | January 2019 Basser Center Executive Director Susan Domchek, MD, discusses the role of specific PARP inhibitors in an ongoing breast cancer trial. Risk-Reducing Mastectomy in BRCA1 and BRCA2 Mutation Carriers Journal of the American Medical Association News | December 2018 Basser Center Executive Director Susan Domchek, MD, discusses the complex issue of risk-reducing mastectomy in BRCA mutation carriers in an editorial for the Journal of the American Medical Association. Blackstone COO Jonathan Gray On Giving To Education, Cancer Research Forbes News | October 2018 Basser Center founders Mindy and Jon Gray have a well-deserved spot on Forbes' annual list of top 50 philanthropists. "In total, Gray has given over $120 million in his lifetime, primarily to cancer research and health and education in New York City." Evening of Storytelling Speaks to Future of Cancer Research Cure Magazine News | October 2018 The Basser Center's Young Leadership Council recently hosted a storytelling event featuring personal stories from three individuals touched by BRCA mutations, which all spoke to the promising future that research will provide for future patients and the newly BRCA-positive population. When Is It Time To Get Preventative Surgeries To Avoid Cancer? KJZZ News | October 2018 Basser Center Executive Director Susan Domchek, MD, joins KJZZ's The Show for an episode devoted to genetic testing, preventative surgery, and raising awareness of hereditary breast cancer. How Men Can Be Affected by the BRCA Gene, Too New York Post News | September 2018 Basser’s Susan Domchek, MD, and Penn Medicine patient Steven Merlin, whose participation in groundbreaking clinical trials using PARP inhibitor drugs has kept him cancer-free for six years, comment on how BRCA mutations affect men. With CRISPR, Scientists Engineered Nearly 4,000 Mutations of a Breast-Cancer Gene The Atlantic News | September 2018 Using CRISPR, a team assessed 3,893 otherwise unstudied mutations of BRCA1, which normally suppresses cancerous tumors, but can be rendered ineffective when they’re mutated. Centenarian Eagles Fan Becomes Social Media Star Jewish Exponent News | August 2018 The Basser family patriarch, Phil Basser, father to the Center's co-founder Mindy Gray and Basser Global Prize co-founder Shari Potter, is featured in the Jewish Exponent for his century of loving Philadelphia football. The club where no one has cancer — yet The Lily News | August 2018 Basser Young Leadership Council member Suzanne Zupello recently penned this personal piece on the importance of support communities for those with BRCA mutations for The Lily. At-Home DNA Tests are Changing How Patients See Themselves WHYY News | July 2018 WHYY's The Pulse sat down with Dana Clark, MS, LCGC, a genetic counselor in the Basser Center, to learn how these services are affecting decisions and outlooks on health. Free Panel to Explore Living with Inherited Cancer Risk The San Diego Tribune News | July 2018 The San Diego Union-Tribune reports on our upcoming panel on hereditary cancer and BRCA in La Jolla, California. Pagination First page« First Previous page‹‹ … Page8 Page9 Page10 Page11 Page12 Current page13 Page14 Page15 Page16 Next page›› Last pageLast »
Volunteering for Cancer Research: An Act of Love Penn Medicine News News Motivated by generations past, present, and future, two patients participating in the first-of-its-kind clinical trial are testing an experimental approach to stop cancer in its tracks at the earliest stages of development at the Basser Center.
Doctors Outline New Discoveries in the Fight to Cure Ovarian Cancer Main Line Times News | May 2019 Mainline Media News profiles the work of Dr. Ronny Drapkin, the Basser Center's Director of Gynecologic Cancer Research.
How to Quell a Cytokine Storm: International Team Finds New Ways to Dampen an Overactive Immune System Penn Medicine News News | May 2019 Researchers at Penn Medicine and University of Leeds, co-led by the Basser's Roger Greenberg, MD, PhD, have deciphered the structure of a multipart, molecular complex that is also responsible for regulating the immune system and have found new molecular targets for fighting autoimmunity.
I Had a Preventive Mastectomy—Then Found Out I Already Had Breast Cancer Yahoo Lifestyle News | May 2019 Alejandra Campoverdi, who has partnered with the Basser Center for our LATINX & BRCA initiative, speaks about her recent preventative mastectomy.
Penn Research Provides Insight into Genetic Link to Potential Treatment Response Among BRCA1/2 Breast Cancer Patients Penn Medicine News News | May 2019 New findings from Penn Medicine researchers, including the study’s senior author, Basser’s Katherine L. Nathanson, MD, provide clues about immune response of tumors in patients with BRCA-related breast cancers. The research could shape treatment strategies and clinical trials.
Pancreatic cancer treatments show promise in studies, Penn reports Philadelphia Inquirer News | April 2019 The Philadelphia Inquirer highlights a Penn Medicine and Basser Center study, led by Kim Reiss Binder, MD, an assistant professor of Hematology-Oncology, which examines PARP inhibitors in patients with BRCA mutations.
Ask the Expert: Senior Genetic Counselor, Dana Clark, Explains BRCA Gene Mutations Health Central News | March 2019 Basser Center genetic counselor Dana Farengo Clark, MS, LCGC, helps to explain BRCA mutations and the process of genetic testing and counseling.
Taking the Uncertainty Out of Interpreting BRCA Variants Journal of the American Medical Association News | March 2019 Basser Executive Director Susan Domchek, MD, discusses a new resource with JAMA that may help guide clinical decision-making related to BRCA genetic mutations.
Lead Researcher Discusses Durvalumab/Olaparib Combo in Breast Cancer OncLive News | January 2019 Basser Center Executive Director Susan Domchek, MD, discusses the role of specific PARP inhibitors in an ongoing breast cancer trial.
Risk-Reducing Mastectomy in BRCA1 and BRCA2 Mutation Carriers Journal of the American Medical Association News | December 2018 Basser Center Executive Director Susan Domchek, MD, discusses the complex issue of risk-reducing mastectomy in BRCA mutation carriers in an editorial for the Journal of the American Medical Association.
Blackstone COO Jonathan Gray On Giving To Education, Cancer Research Forbes News | October 2018 Basser Center founders Mindy and Jon Gray have a well-deserved spot on Forbes' annual list of top 50 philanthropists. "In total, Gray has given over $120 million in his lifetime, primarily to cancer research and health and education in New York City."
Evening of Storytelling Speaks to Future of Cancer Research Cure Magazine News | October 2018 The Basser Center's Young Leadership Council recently hosted a storytelling event featuring personal stories from three individuals touched by BRCA mutations, which all spoke to the promising future that research will provide for future patients and the newly BRCA-positive population.
When Is It Time To Get Preventative Surgeries To Avoid Cancer? KJZZ News | October 2018 Basser Center Executive Director Susan Domchek, MD, joins KJZZ's The Show for an episode devoted to genetic testing, preventative surgery, and raising awareness of hereditary breast cancer.
How Men Can Be Affected by the BRCA Gene, Too New York Post News | September 2018 Basser’s Susan Domchek, MD, and Penn Medicine patient Steven Merlin, whose participation in groundbreaking clinical trials using PARP inhibitor drugs has kept him cancer-free for six years, comment on how BRCA mutations affect men.
With CRISPR, Scientists Engineered Nearly 4,000 Mutations of a Breast-Cancer Gene The Atlantic News | September 2018 Using CRISPR, a team assessed 3,893 otherwise unstudied mutations of BRCA1, which normally suppresses cancerous tumors, but can be rendered ineffective when they’re mutated.
Centenarian Eagles Fan Becomes Social Media Star Jewish Exponent News | August 2018 The Basser family patriarch, Phil Basser, father to the Center's co-founder Mindy Gray and Basser Global Prize co-founder Shari Potter, is featured in the Jewish Exponent for his century of loving Philadelphia football.
The club where no one has cancer — yet The Lily News | August 2018 Basser Young Leadership Council member Suzanne Zupello recently penned this personal piece on the importance of support communities for those with BRCA mutations for The Lily.
At-Home DNA Tests are Changing How Patients See Themselves WHYY News | July 2018 WHYY's The Pulse sat down with Dana Clark, MS, LCGC, a genetic counselor in the Basser Center, to learn how these services are affecting decisions and outlooks on health.
Free Panel to Explore Living with Inherited Cancer Risk The San Diego Tribune News | July 2018 The San Diego Union-Tribune reports on our upcoming panel on hereditary cancer and BRCA in La Jolla, California.